Cardiovascular Risk Reduction# Recommendation : Semaglutide Reason : SELECT demonstrated 20% MACE reduction with semaglutide 2.4 mg in 17,604 patients
Originally designed for diabetes management, GLP-1/GIP medications help regulate blood sugar levels by enhancing insulin production and reducing glucose spikes
The combination of Methionine, Inositol, Choline, and Cyanocobalamin (Vitamin B12) works synergistically to promote weight management, improve liver function, and provide a natural energy boost
Spotlight on the Mechanism of Action of Semaglutide
Eli Lillys Next-Generation GLP-1R Agonist NaperiglipronStructure Revealed | Eli Lilly has disclosed the structure of its next-generation small molecule GLP-1R agonist, naperiglipron (LY3549492)
Gastroprotective and anti-oxidative properties of ascorbic acid on indomethacin-induced gastric injuries in rats